Elias Jabbour

Statistics

Publications

Citations

364

H-Index

Active since

2016

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Universidade do Estado do Rio de Janeiro

Universidade Federal de Santa Catarina

University of California, Irvine Medical Center

Elias Jabbour is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, acute lymphoblastic leukemia therapy, and chemotherapy.

ORCID

Publications per year

2016–2025

Publications

Ponatinib vs Imatinib in Frontline Philadelphia Chromosome–Positive Acute Lymphoblastic Leukemia

Elias Jabbour, Hagop M. Kantarjian, Ibrahim Aldoss et al. · JAMA · 2024 · 114 citations · Full text

Medicine, Oncology, Pharmacology +12

South Korea’s and China’s catching-up: a new-developmentalist analysis

Luiz Carlos Bresser‐Pereira, Elias Jabbour, Luiz Fernando de Paula · Brazilian Journal of Political Economy · 2020 · 44 citations · Full text

Social Sciences, Development Studies, Economics +16

The political economy of reforms and the present Chinese transition

Elias Jabbour, Alexis Toríbio Dantas · Brazilian Journal of Political Economy · 2017 · 36 citations · Full text

Social Sciences, Economic Development Planning, Economics +17

Combination of ponatinib and blinatumomab in Philadelphia chromosome-positive acute lymphoblastic leukemia: Early results from a phase II study.

Nicholas J. Short, Hagop M. Kantarjian, Marina Konopleva et al. · Journal of Clinical Oncology · 2021 · 29 citations

Medicine, Hematology, Pharmacology +15

China and Market Socialism: A New Socioeconomic Formation

Elias Jabbour, Alexis Toríbio Dantas, Carlos José Espíndola · International Critical Thought · 2021 · 25 citations

Social Sciences, Economics, Sociology +15

1–5 of 13